RecruitingNot ApplicableNCT06826235

Investigation of the Effect of Date Consumption on Hedonic Hunger and Appetite in Adult Individuals With Type 2 Diabetes

Tip 2 Diyabetli Yetişkin Bireylerde Hurma Tüketiminin Hedonik Açlık ve İştah Hormonları Üzerine Etkilerinin İncelenmesi

Sponsor

Hacettepe University

Enrollment

64 participants

Start Date

May 14, 2024

Study Type

INTERVENTIONAL

Conditions

Type 2 Diabetes Mellitus Appetite

Summary

The aim of this study was to investigate the effects of date consumption on hedonic hunger and appetite hormones in individuals diagnosed with type 2 diabetes.The main questions it aims to answer are: * Does date consumption reduce hedonic hunger in individuals with type 2 diabetes? * Does persimmon consumption change Ghrelin, GLP-1 and GIP concentrations in individuals with Type 2 diabetes? * Does persimmon consumption reduce HOMA-IR and HbA1c values in individuals with Type 2 diabetes? * Does consumption of persimmon reduce LDL cholesterol, total cholesterol and triglyceride concentrations in individuals with type 2 diabetes? To see the effects of date consumption on hedonic hunger and appetite hormones, the researchers will compare individuals with type 2 diabetes who consume 3 dates daily with individuals with type 2 diabetes who do not. Participants: * Individuals in the intervention group will consume 3 (25 g) Baghdad dates (15 g CHO) daily as part of the breakfast meal, while individuals in the control group will not consume dates. * Three interviews will be conducted with patients. * A record of blood findings and questionnaires will be kept during these interviews.

Eligibility

Min Age: 19 YearsMax Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating whether eating dates (the fruit) affects "hedonic hunger" — the desire to eat for pleasure rather than out of physical hunger — and overall appetite and food intake in healthy adults. **You may be eligible if...** - You are an adult in good general health - You do not have food allergies to dates or related fruits - You are not currently on a strict diet for medical reasons - You are willing to consume dates and complete food and appetite questionnaires **You may NOT be eligible if...** - You have diabetes or blood sugar problems (dates are high in natural sugars) - You have a fructose intolerance or irritable bowel syndrome triggered by high-FODMAP foods - You are pregnant or breastfeeding - You have an eating disorder - You dislike or cannot consume dates for dietary or religious reasons Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHER3 dates at the breakfast meal in the diet program

Participants in the intervention group will consume 3 dates at the breakfast meal in the diet program.

Locations(1)

Erzurum City Hospital

Erzurum, Palandöken, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06826235

Related Trials

POLUS: Description of the Effectiveness and Tolerability of Luseogliflozin in Patients With Type 2 Diabetes.

NCT074331921 location

Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa

NCT058814471 location

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

NCT0735105836 locations

An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea

NCT072325371 location

Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in Range Compared With Self-Monitoring of Blood Glucose in Participants With Type 1 and Type 2 Diabetes Mellitus

NCT0670467216 locations